A new arm of a clinical trial has begun testing Knoa Pharma‘s experimental therapy tinostamustine in people with glioblastoma,…
Articles by Marisa Horak, MS
A protein called IRF2 may help drive myeloma, and measuring its levels could help predict outcomes among people with…
U.S. authorities have granted a permanent billing code for Blenrep (belantamab mafodotin), an approved treatment for certain adults with…
A regulatory committee in the European Union has recommended expanding approval of a dual regimen…
A European Medicines Agency (EMA) committee is recommending expanded approval for Jaypirca (pirtobrutinib), an oral therapy used to treat chronic…
The European Commission has approved a new subcutaneous (under-the-skin) formulation of Sarclisa (isatuximab), a treatment for multiple myeloma…
The U.S. Food and Drug Administration (FDA) has approved a new formulation of the anticancer therapy nilotinib, branded Cavhanza, to…
Ideaya Biosciences and Roche announced a collaboration to test two experimental treatments for pancreatic cancer in combination.
Add-on treatment with DeltEx DRI, a cell therapy being developed by In8bio, may help prolong survival in people with…
A combination of the immune-modulating treatments Lymphir (denileukin diftitox) and Keytruda (pembrolizumab) led to clinical benefit in nearly half of…